These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32962636)

  • 21. Identification of key genes in endometrioid endometrial adenocarcinoma via TCGA database.
    Liu Y; Nan F; Lu K; Wang Y; Liu Y; Wei S; Wu R; Wang Y
    Cancer Biomark; 2017 Dec; 21(1):11-21. PubMed ID: 29060924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A microRNA-Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer.
    Liu J; Yang J; Gao F; Li S; Nie S; Meng H; Sun R; Wan Y; Jiang Y; Ma X; Cheng W
    DNA Cell Biol; 2020 Jul; 39(7):1328-1346. PubMed ID: 32456463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
    Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
    Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening key genes and miRNAs in early-stage colon adenocarcinoma by RNA-sequencing.
    Liu J; Liu F; Li X; Song X; Zhou L; Jie J
    Tumour Biol; 2017 Jul; 39(7):1010428317714899. PubMed ID: 28714374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
    Jin X; Guan Y; Zhang Z; Wang H
    BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
    Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
    Gene; 2019 May; 697():86-93. PubMed ID: 30779946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
    Sharma P; Saraya A; Sharma R
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
    Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
    Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p.
    Peng Z; Xu B; Jin F
    Technol Cancer Res Treat; 2020; 19():1533033820928471. PubMed ID: 32462972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium.
    Pils D; Bachmayr-Heyda A; Auer K; Svoboda M; Auner V; Hager G; Obermayr E; Reiner A; Reinthaller A; Speiser P; Braicu I; Sehouli J; Lambrechts S; Vergote I; Mahner S; Berger A; Cacsire Castillo-Tong D; Zeillinger R
    Eur J Cancer; 2014 Jan; 50(1):99-110. PubMed ID: 24176298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.
    Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W
    Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profiling of microRNA-mRNA reveals roles of microRNAs in cervical cancer.
    Ma D; Zhang YY; Guo YL; Li ZJ; Geng L
    Chin Med J (Engl); 2012 Dec; 125(23):4270-6. PubMed ID: 23217399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
    Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
    J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of the tumor-specific ceRNA network in epithelial ovarian cancer.
    Li G; Han L; Ren F; Zhang R; Qin G
    J Cell Physiol; 2019 Dec; 234(12):22071-22081. PubMed ID: 31152442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
    Liu H; Liu L; Zhu H
    J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA.
    Liu J; Wu Z; Sun R; Nie S; Meng H; Zhong Y; Nie X; Cheng W
    Life Sci; 2020 Oct; 258():118231. PubMed ID: 32791150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.
    Guo S; Yang J; Wu M; Xiao G
    Pathol Res Pract; 2019 May; 215(5):1003-1011. PubMed ID: 30910254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.
    Nakayama K; Rahman MT; Rahman M; Nakamura K; Ishikawa M; Katagiri H; Sato E; Ishibashi T; Iida K; Ishikawa N; Kyo S
    Int J Oncol; 2016 Feb; 48(2):506-16. PubMed ID: 26647729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of differentially expressed microRNAs in endometrial cancer cells after progesterone treatment.
    Bae J; Won M; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH; Suh DS
    Int J Gynecol Cancer; 2012 May; 22(4):561-5. PubMed ID: 22543862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.